Posted in | News

Sumitomo/Lyondell to Build Propylene Glycol Plant

Sep 19 2003

Related Stories

Nihon Oxirane, the joint venture of Sumitomo Chemical and Lyondell Chemical Company intend to build a propylene glycol plant in Chiba, Japan.

The proposed plant is due for completion before the end of 2004 and will have a capacity of 100,000 tons. The plant will license technology from Lyondell and use their Asian marketing network.

The joint venture already manufactures propylene oxide which from which propylene glycol is derived. Nihon Oxirane currently sells propylene oxide into the Asian and Middle Eastern markets.

Propylene glycol is used in products such as surfactants, food additives, moisturizers and personal care products.

For more information on cosmetics, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback